Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation

  title={Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation},
  author={Richard C. Wang and Yongjie Wei and Zhenyi An and Zhongju Zou and Guanghua Xiao and G. Bhagat and Michael White and Julia Reichelt and Beth Levine},
  pages={956 - 959}
Getting Autophagy to Akt The protein kinase Akt is often activated in human cancers and is thought to promote tumor formation. One way in which it may do so is to inhibit autophagy (a process by which the cell digests its own proteins or organelles, especially damaged ones). Wang et al. (p. 956, published online 25 October; see the Perspective by Koren and Kimchi) provide a direct molecular mechanism by which Akt regulates autophagy. Beclin, a component of the autophagy machinery, appears to be… 

The interplay of ROS and the PI3K/Akt pathway in autophagy regulation

Studies conducted on cells treated with flavonoids and ionizing radiation showed that the moderate increase in ROS levels in the flavonoid‐treated groups corresponded with higher PTEN levels and lowered Akt levels leading to a higher occurrence of autophagy, in contrast, higher ROS levels evoked by ionizing Radiation caused a lowering of the incidence of autphagy.

Regulation of autophagy by Beclin 1 in the heart.

Autophagy processes are dependent on EGF receptor signaling

The hypothesis that the activation of the EGFR is a necessary event that allows the ignition and progression of the autophagic process, at least in melanoma cells is advanced.

Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia

It is shown that Beclin-1 knockdown, but not Atg5 deletion in a murine CML model leads to a reduced leukemic burden and results in a significantly prolonged median survival of targeted mice.

Promoting Tumorigenesis by Suppressing Autophagy

A connection between Beclin 1 and the Akt signaling pathway is established, which controls a large spectrum of cellular functions associated with cancer ranging from cell proliferation and survival to angiogenesis and metabolism, and underscores the importance of autophagy in tumor suppression.

Autophagy-Independent Role for Beclin 1 in the Regulation of Growth Factor ReceptorSignaling: A Dissertation

A novel role for Beclin 1 in regulating growth factor signaling is identified and a mechanism by which loss of BeClin 1 expression would enhance breast cancer progression independent of its impact on autophagy is revealed.

Enhanced Autophagy in GAB1-Deficient Vascular Endothelial Cells Is Responsible for Atherosclerosis Progression

This study first suggests that GAB1 is a key regulator of autophagy in HUVECs, and Targeting GAB 1 may serve as a potential strategy for the atherosclerosis treatment.

AMPK regulates autophagy by phosphorylating BECN1 at threonine 388

It is shown that AMP-activated protein kinase (AMPK) regulates autophagy by phosphorylating BECN1 at Thr388, uncovering a novel mechanism of Autophagy regulation.

Induction of autophagy and inhibition of tumorigenesis by beclin 1

It is shown that beclin 1 is a mammalian autophagy gene that can inhibit tumorigenesis and is expressed at decreased levels in human breast carcinoma, suggesting that decreased expression of Autophagy proteins may contribute to the development or progression of breast and other human malignancies.

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents

It is shown that silencing Akt1 alone, or any combination of Akt isoforms, can suppress the growth of tumors established from phosphatase and tensin homologue–null human cancer cells, and suggests that blocking lysosomal degradation can be detrimental to cancer cell survival when autophagy is activated.

Perturbations of the AKT signaling pathway in human cancer

Various pathogenic mechanisms contributing to activation of the AKT pathway in human malignancy as well as current pharmacologic strategies to target therapeutically components of this pathway are reviewed.

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

The identification of a somatic mutation in human breast, colorectal and ovarian cancers that results in a glutamic acid to lysine substitution at amino acid 17 (E17K) in the lipid-binding pocket of AKT1 is reported.

The Beclin 1 interactome.

A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth

Keratin 17, an intermediate filament protein rapidly induced in wounded stratified epithelia, regulates cell growth through binding to the adaptor protein 14-3-3σ, revealing a new and unexpected role for the intermediate filament cytoskeleton in influencing cell growth and size by regulating protein synthesis.

Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.

Combined EGFR/mTOR kinase inhibition inhibits tumor cell growth and has an additive effect on inhibiting downstream PI3K pathway signaling and combination therapy provides added benefit in promoting cell death in PTEN-deficient tumor cells.

PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.

It is shown for the first time that loss of PTEN contributes to intrinsic BRAF inhibitor resistance via the suppression of BIM-mediated apoptosis.